Cronos Group Inc. (CRON) stock
Close on Nov 11, 2026Market cap $1.27BP/E 20.3Yield –
Cronos Group Inc. grew revenue 55.8% to $206.20M over the twelve months to Sep 30, 2026. Free cash flow was $65.38M. At the latest close the market valued the company at $1.27B, 20.3 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $1.27B
- P/E ratio
- 20.3
- Price to sales
- 6.16
- Price to book
- 1.19
- Dividend yield
- –
- Free cash flow yield
- 5.14%
Fundamentals
- Revenue
- $206.20M
- Net income
- $57.83M
- EPS, diluted
- $0.17
- Free cash flow
- $65.38M
- Book value per share
- $2.89
- Diluted shares
- 371M
Trading
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Previous close
- $3.41
- Open
- $3.41
- Day's range
- $3.36 – $3.48
- Volume
- 1,072,952
- Average volume (20 days)
- 1,166,004
- Beta (5 years)
- 0.85
- 52-week range
- $2.28 – $3.91
- RSI (14 days)
- 53.6
- Volatility (1 year)
- 40.4%
- Relative volume
- 0.97×
- WACC
- 9.1%
Market cap history
Month-end market cap since 2017, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | CRON | S&P 500 | Difference | CRON per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +6.8% | -2.4% | +9.2 pts | ||
| 3 months | +12.0% | -1.2% | +13.2 pts | ||
| Year to date | +31.2% | +12.3% | +18.9 pts | ||
| 1 year | +36.9% | +12.4% | +24.5 pts | ||
| 3 years | +67.5% | +78.8% | −11.3 pts | +18.8% | +21.4% |
| 5 years | -39.3% | +75.2% | −114.4 pts | -9.5% | +11.9% |
| 10 years | +34400.0% | +311.1% | +34088.9 pts | +79.4% | +15.2% |
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Cronos filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Results
- Update
About Cronos
Medicinal Chemicals & Botanical Products
Cronos is a cannabinoid company that develops, produces, and markets cannabis products and intellectual property. The company operates through a single consolidated reporting segment covering its Canadian and Israeli operations. Its commercial brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. Product offerings encompass dried cannabis flower, pre-rolls, vaporizers, edibles, extracts, and tinctures for adult-use and medical applications. The company distributes products to provincial cannabis control authorities, private-sector retailers, and medical patients through pharmacy and third-party distribution channels.
Company profile, executives and historyCronos stock: common questions
What is Cronos's stock price?
CRON closed at $3.45 on Nov 11, 2026, up 1.17% on the day. Over the past 52 weeks it traded between $2.28 and $3.91.
What is Cronos's market cap?
Cronos was worth $1.27B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is CRON's P/E ratio?
CRON trades at 20.3 times earnings, based on diluted earnings per share of $0.17 over the twelve months to Sep 30, 2026.
How much revenue does Cronos make?
Cronos reported revenue of $206.20M for the twelve months to Sep 30, 2026, up 55.8% from a year earlier.
Does Cronos pay a dividend?
No. Cronos has not paid a cash dividend over the last twelve months.
When does Cronos report earnings next?
Cronos is expected to report Q4 FY2026 results on Feb 25, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has CRON stock performed over the past year?
Including dividends, CRON returned +36.9% over the past year, against +12.4% for the S&P 500.
How many CRON shares are sold short?
4M shares were sold short at the latest FINRA report, 1.21% of the float, or 4.9 days of average trading volume.
Who are Cronos's competitors?
Companies most similar to Cronos by business, industry and size include CGC, ACB, GLAS, MRMD, JUSH.
See a number that looks wrong?